Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1997-03-25
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514365, 514422, 548204, 548517, 548526, 548527, 548533, 548538, C07D20716, A61K 3140
Patent
active
056145470
ABSTRACT:
This invention relates to neurotrophic compounds having an affinity for FKBP-type immunophilins, their preparation and use as inhibitors of the enzyme activity associated with immunophilin proteins, and particularly inhibitors of peptidyl-prolyl isomerase or rotamase enzyme activity.
REFERENCES:
patent: 5192773 (1993-03-01), Armistead et al.
patent: 5330993 (1994-07-01), Armistead et al.
patent: 5385918 (1995-01-01), Connell et al.
Hauske, James R. et al., "Design and Synthesis of Novel FKBP Inhibitors," J. Med. Chem., 1992, 35, pp. 4284-4296.
Holt, Dennis A. et al., "Structure-Activity Studies of Nonmacrocyclic Rapamycin Derivatives," Bioorganic & Medical Chemistry Letters, 1993, vol. 3, No. 10, pp. 1977-1980.
Yamashita, Dennis S. et al., "Design Synthesis and Evaluuation of Dual Domain FKBP Ligands," Bioorganic & Medicinal Chemistry Letters, 1994, vol. 4, No. 2 pp. 325-328.
Teague, Simon J. et al., "Synthesis and Study of a Non Macrocyclic FK506 Derivative," Bioorganic & Medical Chemistry Letters, 1994, vol. 4, No. 13, pp. 1581-1584.
Luengo, Juan I. et al., "Synthesis and Structure-Activity Relationships of Macrocyclic FKBP Ligands," Bioorganic & Medicinal Chemistry Letters, 1994, vol. 4, No. 2, pp. 321-324.
Holt, Dennis A. et al., "Structure-Activity Studies of Synthetic FKBP Ligands as Peptidyl-Prolyl Isomerase Inhibitors," Bioorganic & Medicinal Chemistry Letters, 1994, vol. 4, No. 2, pp. 315-320.
Teague, Simon J. et al., "The Affinity of the Excised Binding Dommain of FK-506 for the Immunophilin FKBP12," Bioorganic & Medicinal Chemistry Letters, 1993, vol. 3, No. 10, pp. 1947-1950.
Caffrey, Moya V. et al., "Synthesis and Evaluation of Dual Domain Macrocyclic FKBP12 Ligands," Bioorganic & Medicinal Chemistry Letters, 1994, vol. 4, No. 21, pp. 2507-2510.
Birkenshaw, Timothy N. et al., "Synthetic FKBP12 Ligands. Design and Synthesis of Pyranose Replacements," Bioorganic & Medicinal Chemistry Letters, 1994, vol. 4, No. 21, pp. 2501-2506.
Holt, Dennis A. et al., "Design, Synthesis, and Kinetic Evaluation of High-Affinity FKBP Ligands and the X-ray Crystal Structures of Their Complexes with FKBP12," J. Am. Chem. Soc., 1993, 115, pp. 9925-9938.
Wang, Gary T. et al., "Synthesis and FKBP Binding of Small Molecule Mimics of the Tricarbonyl Region of FK506," Bioorganic & Medicinal Chemistry Letters, 1994, vol. 4, No. 9, pp. 1161-1166.
Snyder, Solomon H. and Sabatini, David M., "Immunophilins and the Nervous System," Nature Medicine, 1995, vol. 1, No. 1, pp. 32-37.
Stocks, Michael J. et al., "The Contribution to Binding of the Pyranoside Substitutents in the Excised Binding Domain of FK-506," Bioorganic & Medicinal Chemistry Letters, 1994, vol. 4, No. 12, pp. 1457-1460.
Hamilton Gregory S.
Steiner Joseph P.
Gerstl Robert
Guilford Pharmaceuticals Inc.
Nath Gary M.
LandOfFree
Small molecule inhibitors of rotamase enzyme does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Small molecule inhibitors of rotamase enzyme, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Small molecule inhibitors of rotamase enzyme will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2203833